Intuitive Surgical, Inc. (NASDAQ:ISRG) Shares Sold by Wellington Shields Capital Management LLC

Wellington Shields Capital Management LLC decreased its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 2.5% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 7,675 shares of the medical equipment provider’s stock after selling 200 shares during the quarter. Wellington Shields Capital Management LLC’s holdings in Intuitive Surgical were worth $4,006,000 as of its most recent filing with the SEC.

A number of other institutional investors and hedge funds have also recently bought and sold shares of the business. Massachusetts Financial Services Co. MA bought a new stake in shares of Intuitive Surgical in the third quarter worth $558,807,000. Proficio Capital Partners LLC grew its holdings in Intuitive Surgical by 89,098.8% during the 4th quarter. Proficio Capital Partners LLC now owns 949,967 shares of the medical equipment provider’s stock worth $495,845,000 after acquiring an additional 948,902 shares in the last quarter. FMR LLC increased its position in shares of Intuitive Surgical by 8.3% in the 3rd quarter. FMR LLC now owns 10,971,085 shares of the medical equipment provider’s stock worth $5,389,765,000 after purchasing an additional 838,793 shares during the last quarter. Raymond James Financial Inc. acquired a new stake in shares of Intuitive Surgical in the 4th quarter valued at about $313,769,000. Finally, Wilmington Savings Fund Society FSB lifted its position in shares of Intuitive Surgical by 15,322.2% during the third quarter. Wilmington Savings Fund Society FSB now owns 555,661 shares of the medical equipment provider’s stock worth $272,980,000 after purchasing an additional 552,058 shares during the last quarter. Hedge funds and other institutional investors own 83.64% of the company’s stock.

Intuitive Surgical Price Performance

Shares of Intuitive Surgical stock opened at $476.78 on Friday. The company has a market capitalization of $169.82 billion, a P/E ratio of 74.38, a PEG ratio of 5.85 and a beta of 1.43. Intuitive Surgical, Inc. has a 1-year low of $364.17 and a 1-year high of $616.00. The business’s fifty day moving average price is $568.47 and its two-hundred day moving average price is $531.22.

Insider Buying and Selling

In related news, EVP Brian Edward Miller sold 8,900 shares of the firm’s stock in a transaction that occurred on Tuesday, March 11th. The shares were sold at an average price of $485.07, for a total transaction of $4,317,123.00. Following the completion of the sale, the executive vice president now directly owns 5,758 shares in the company, valued at approximately $2,793,033.06. This trade represents a 60.72 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, CFO Jamie Samath sold 94 shares of the firm’s stock in a transaction on Wednesday, January 29th. The stock was sold at an average price of $571.11, for a total value of $53,684.34. Following the sale, the chief financial officer now directly owns 2,630 shares of the company’s stock, valued at approximately $1,502,019.30. This represents a 3.45 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 22,209 shares of company stock valued at $11,928,127 over the last 90 days. 0.90% of the stock is currently owned by company insiders.

Analyst Ratings Changes

Several analysts recently weighed in on ISRG shares. Citigroup boosted their price objective on Intuitive Surgical from $640.00 to $711.00 and gave the company a “buy” rating in a report on Friday, January 24th. Erste Group Bank upgraded Intuitive Surgical from a “hold” rating to a “buy” rating in a report on Tuesday, November 19th. CICC Research began coverage on Intuitive Surgical in a research note on Monday, January 27th. They set a “neutral” rating and a $550.00 price objective on the stock. Jefferies Financial Group boosted their target price on shares of Intuitive Surgical from $475.00 to $575.00 in a research note on Monday, January 27th. Finally, Bernstein Bank increased their target price on shares of Intuitive Surgical from $655.00 to $700.00 and gave the stock an “overweight” rating in a report on Monday, January 27th. One investment analyst has rated the stock with a sell rating, four have given a hold rating and sixteen have given a buy rating to the company. According to MarketBeat.com, Intuitive Surgical presently has a consensus rating of “Moderate Buy” and a consensus price target of $613.10.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.